eNewsroom for: Atlantic Pharmaceuticals Inc.

http://www.ereleases.com/pr/wp-content/Cimy_User_Extra_Fields/Atlantic Pharmaceuticals Inc./logo.jpg

Atlantic Pharmaceuticals Inc. Company Profile

Atlantic Pharmaceuticals, Inc., is a privately held specialty pharmaceutical company dedicated to the discovery and development of innovative, late-stage therapies for substance abuse and pain-related conditions and diseases. Our products target therapeutic opportunities utilizing molecules shown to be safe and effective with formulations that are protected by intellectual property. We believe that our approach will lead to improved patient care, reduced healthcare costs and a rapid time to market.

News from Atlantic Pharmaceuticals Inc.:

Atlantic Pharmaceuticals, Inc. Announces Third Patent Issuance on SMART/Script™ Abuse Deterrent Drug Delivery System

ATLANTA, Aug. 21, 2013 /PRNewswire/ – Atlantic Pharmaceuticals, Inc., today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,507,001 that contains claims which cover Atlantic’s SMART/Script™ abuse deterrent drug delivery system…

Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone

ATLP-03 uses SMART/Script™ drug delivery technology to deter prescription drug abuse
ATLANTA, Aug. 13, 2013 /PRNewswire/ — Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company that has developed and is commercializing a unique technology to deter prescription drug a…

Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology

ATLANTA, May 20, 2013 /PRNewswire/ – Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company that has developed and is commercializing a unique technology to deter prescription drug abuse today announced that its founder and President, Anthony Soscia, has been chosen as a fina…

Atlantic Pharmaceuticals, Inc. Announces Two Patent Issuances for Its Tamper-Resistant Pharmaceutical Platform

ATLANTA, Dec. 20, 2012 /PRNewswire/ – Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that new patents have been issued by the U.S. Patent and Trademark Office (USPTO) relating to its tamper-resistant SMART/Script™ drug delivery platform. U.S. Pat…

Atlantic Pharmaceuticals, Inc. Announces Completion of Successful Pre-IND Meeting with FDA for Abuse Deterrent Narcotic

ATLANTA, June 23, 2009 — Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that it has completed a pre-investigational new drug (PIND) meeting with the Food and Drug Administration (FDA) for guidance on a mutually acceptable regulatory pathway for submiss…